QALGX
Price
$42.20
Change
-$0.12 (-0.28%)
Updated
Jun 2 closing price
Net Assets
5.67B
VIGRX
Price
$278.08
Change
-$0.79 (-0.28%)
Updated
Jun 2 closing price
Net Assets
365B
Interact to see
Advertisement

QALGX vs VIGRX

Header iconQALGX vs VIGRX Comparison
Open Charts QALGX vs VIGRXBanner chart's image
QALGX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
QALGX vs. VIGRX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QALGX is a Hold and VIGRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 365B vs. QALGX (5.67B). VIGRX pays higher dividends than QALGX: VIGRX (0.26) vs QALGX (0.00). QALGX was incepted earlier than VIGRX: QALGX (21 years) vs VIGRX (34 years). QALGX (1.11) is less costly to investors than VIGRX (0.17). QALGX is a more actively managed with annual turnover of: 58.00 vs. VIGRX (12.00). VIGRX has a lower initial minimum investment than QALGX: VIGRX (0) vs QALGX (1500). VIGRX annual gain was more profitable for investors over the last year : 30.14 vs. QALGX (23.78). VIGRX return over 5 years is better than : 102.52 vs. QALGX (50.98).
QALGXVIGRXQALGX / VIGRX
Total Expense Ratio1.000.17588%
Annual Report Gross Expense Ratio1.110.17653%
Fund Existence21 years34 years-
Gain YTD10.52511.00296%
Front Load6%N/A-
Min. Initial Investment15000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.67B365B2%
Annual Yield % from dividends0.000.26-
Returns for 1 year23.7830.1479%
Returns for 3 years88.1799.8088%
Returns for 5 years50.98102.5250%
Returns for 10 years190.86401.3048%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INDP2.150.23
+11.98%
Indaptus Therapeutics Inc
MDLZ61.070.02
+0.03%
Mondelez International
PWP16.16-0.53
-3.18%
Perella Weinberg Partners
LYFT14.11-0.75
-5.05%
Lyft
KTTA0.64-0.07
-9.79%
Pasithea Therapeutics Corp